Osteoporosis Disease Management Demonstration Project (0000-037)

Merck Sharp & Dohme (MSD)

Status: Completed

Conditions: Osteoporosis

Treatments: Behavioral: Disease Management Assessment

Study type: Interventional

Funder types: Industry

Identifiers

NCT00139425

037

2005_048

0000-037

Details and patient eligibility

About

The purpose of this study is to assess the impact of disease management interventions on bone mineral density (BMD) screening rates and osteoporosis treatment rates in women age 65 years or older.

Sex: Female

Ages: 65 to 89 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Members of the Henry Ford Health System

Exclusion criteria

• Individuals who are not members of the Henry Ford Health System